close
MENU
Business
3 mins to read

Aussie VC investor wants liberalisation of trans-Tasman market

Australian VC law treats New Zealand as the ‘rest of the world’. It doesn’t have to be that way.

Hashan De Silva bought into Neuren at A$1 and the stock is at A$20 today on the ASX.

Australian biotech investor Hashan De Silva would like to be free to invest as much of his venture capital fund in New Zealand as he liked, but is restricted by Australian legislation he believes should be modified.

Under the Venture Capital Act, originally passed in 2002, VC funds are only able to

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Lachlan Colquhoun Tue, 11 Jun 2024
Contact the Writer: lachlan@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Aussie VC investor wants liberalisation of trans-Tasman market
Business,
104407
true